YaoGeJu

Company directoryChina company filings

Chengdu Kanghong Pharmaceutical Group Co.,Ltd.

As of 17 November 2026, for the company name Chengdu Kanghong Pharmaceutical Group Co.,Ltd. as recorded, 2 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 61 records, across 28 drug names; since 21 August 2026, the records list Marketing application approved: 1 application; the chemical-drug catalogue lists 21 active records with this name as holder.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/17
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.

Drug filings

61 acceptance records as first applicant, grouped into 28 source drug names. Source data as of 2026/11/17.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Vortioxetine Hydrobromide Tablets 1 records · Latest accepted 2026/02/14

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600358Supplement2026/02/14Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
KHN707片 · No verified English name 2 records · Latest accepted 2025/12/16

New drug · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2501387New drug2025/12/16Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2501386New drug2025/12/16Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Vonoprazan Fumarate Tablets 4 records · Latest accepted 2025/10/21

Supplement · 2Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2502146Supplement2025/10/21Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHB2502145Supplement2025/10/21Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHS2201711Generic2022/10/12Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHS2201710Generic2022/10/12Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Apalutamide Tablets 1 records · Latest accepted 2025/08/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503102Generic2025/08/23Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Chongqing Bo Teng Pharma Co., Ltd. romanizedCDE ↗
Amisulpride Oral Solution 1 records · Latest accepted 2025/08/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502767Generic2025/08/01Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Tai Ji Group Sichuan Tai Ji Pharmaceutical Co., Ltd. romanizedCDE ↗
Ibrutinib Capsules 1 records · Latest accepted 2025/06/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502292Generic2025/06/27Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Sodium Hyaluronate Eye Drops 4 records · Latest accepted 2025/04/08

Supplement · 3Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500697Supplement2025/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Ningxia Kang Ya Pharma Co., Ltd. romanizedCDE ↗
CYHB2500696Supplement2025/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Ningxia Kang Ya Pharma Co., Ltd. romanizedCDE ↗
CYHB2500695Supplement2025/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Ningxia Kang Ya Pharma Co., Ltd. romanizedCDE ↗
CYHS2301831Generic2023/07/07Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Ningxia Kang Ya Pharma Co., Ltd. romanizedCDE ↗
KH607片 · No verified English name 5 records · Latest accepted 2025/02/28

New drug · 5

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2500224New drug2025/02/28Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2500223New drug2025/02/28Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2300513New drug2023/05/12Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2300512New drug2023/05/12Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2300511New drug2023/05/12Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Perampanel Tablets 2 records · Latest accepted 2025/02/08

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500621Generic2025/02/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHS2500620Generic2025/02/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
KHN702片 · No verified English name 3 records · Latest accepted 2025/01/11

New drug · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2500057New drug2025/01/11Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2500056New drug2025/01/11Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2500055New drug2025/01/11Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Brexpiprazole Orally Disintegrating Tablets 3 records · Latest accepted 2024/09/07

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402954Generic2024/09/07Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHS2402952Generic2024/09/07Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHS2402951Generic2024/09/07Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
KH629片 · No verified English name 6 records · Latest accepted 2024/08/09

New drug · 6

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2400799New drug2024/08/09Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2400798New drug2024/08/09Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2400797New drug2024/08/09Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2301036New drug2023/09/26Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2301035New drug2023/09/26Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2301034New drug2023/09/26Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Brexpiprazole Tablets 2 records · Latest accepted 2024/07/30

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402398Generic2024/07/30Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHS2402397Generic2024/07/30Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Mirabegron Extended-release Tablets 1 records · Latest accepted 2024/06/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401877Generic2024/06/25Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Epalrestat Tablets 1 records · Latest accepted 2024/04/17

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401145Generic2024/04/17Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Tofacitinib Citrate Extended Release tablets 1 records · Latest accepted 2023/09/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302608Generic2023/09/27Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
立他司特滴眼液 · No verified English name 2 records · Latest accepted 2023/09/11

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302444Generic2023/09/11Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Chengdu Pusch Pharmaceutical Co., Ltd.CDE ↗
CYHL2100005Generic2021/01/25Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Quetiapine Fumarate Tablets 3 records · Latest accepted 2023/09/02

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302363Generic2023/09/02Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHS2302362Generic2023/09/02Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHS2302361Generic2023/09/02Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Aripiprazole Orally Disintegrating tablets 1 records · Latest accepted 2023/08/21

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301855Supplement2023/08/21Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Venlafaxine Hydrochloride Extended Release Tablets 2 records · Latest accepted 2023/04/15

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2300784Supplement2023/04/15Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHB2300376Supplement2023/02/23Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Pranoprofen Eye Drops 1 records · Latest accepted 2023/03/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300905Generic2023/03/27Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Chongqing Ke Rui Pharmaceutical (Group) Co., Ltd. romanizedCDE ↗
Pimavanserin Tartrate Capsules 1 records · Latest accepted 2022/08/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2200072Generic2022/08/22Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Escitalopram Oxalate Tablets 2 records · Latest accepted 2022/07/07

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201028Generic2022/07/07Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHS2201027Generic2022/07/07Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Cariprazine hydrochloride Capsules 4 records · Latest accepted 2022/04/08

Generic · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2200031Generic2022/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHL2200030Generic2022/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHL2200029Generic2022/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHL2200028Generic2022/04/08Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Obeticholic Acid Tablets 2 records · Latest accepted 2022/02/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2200014Generic2022/02/10Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CYHL2200013Generic2022/02/10Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
草酸艾司西酞普兰口服溶液 · No verified English name 1 records · Latest accepted 2021/08/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101584Generic2021/08/16Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Chengdu Di Kang Pharma Co., Ltd. romanizedCDE ↗
KH737滴眼液 · No verified English name 3 records · Latest accepted 2021/08/03

New drug · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2101366New drug2021/08/03Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2101365New drug2021/08/03Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
CXHL2101364New drug2021/08/03Chengdu Kanghong Pharmaceutical Group Co.,Ltd.CDE ↗
Aripiprazole Oral Solution 1 records · Latest accepted 2021/03/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2100298Supplement2021/03/12Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Guo Yao Group Yi Bin Pharmaceutical Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

1 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Marketing application approved: 1 application

  1. 2026/11/03Marketing application approved

    Ibrutinib Capsules

    CYHS2502292 · 国药准字H20266472

    Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06

    View source · Table row 86 ↗

Under review

2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Apalutamide Tablets CYHS2503102Generic2025/08/23Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Chongqing Bo Teng Pharma Co., Ltd. romanizedCDE ↗
Amisulpride Oral Solution CYHS2502767Generic2025/08/01Chengdu Kanghong Pharmaceutical Group Co.,Ltd.; Tai Ji Group Sichuan Tai Ji Pharmaceutical Co., Ltd. romanizedCDE ↗

Catalogue holder records

21 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Perampanel TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202643992026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Perampanel TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202644002026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Brexpiprazole TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202563892025/12/22Generic approved under the new chemical-drug registration classificationCDE ↗
Brexpiprazole TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202563882025/12/22Generic approved under the new chemical-drug registration classificationCDE ↗
Mirabegron Extended-release TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202559602025/11/18Generic approved under the new chemical-drug registration classificationCDE ↗
Epalrestat TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202555722025/09/23Generic approved under the new chemical-drug registration classificationCDE ↗
Tofacitinib Citrate Extended Release tabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202494362024/11/22Generic approved under the new chemical-drug registration classificationCDE ↗
Quetiapine Fumarate TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202493652024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
Quetiapine Fumarate TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202493642024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
Quetiapine Fumarate TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202493662024/11/15Generic approved under the new chemical-drug registration classificationCDE ↗
Escitalopram Oxalate TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202345932023/12/05Not stated by sourceCDE ↗
Escitalopram Oxalate TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202345922023/12/05Generic approved under the new chemical-drug registration classificationCDE ↗
Vortioxetine Hydrobromide TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202138442021/11/03Generic approved under the new chemical-drug registration classificationCDE ↗
Pramipexole Dihydrochloride Prolonged-release TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202136722021/08/25Not stated by sourceCDE ↗
Pramipexole Dihydrochloride Prolonged-release TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202136732021/08/25Generic approved under the new chemical-drug registration classificationCDE ↗
Mosapride Citrate TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H199903132020/12/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Venlafaxine Hydrochloride Extended Release TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H200702692019/10/23Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Aripiprazole Orally Disintegrating tabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H200605212018/12/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Aripiprazole Orally Disintegrating tabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H200605222018/12/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Vonoprazan Fumarate TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202444252024/07/09Generic approved under the new chemical-drug registration classificationCDE ↗
Vonoprazan Fumarate TabletsChengdu Kanghong Pharmaceutical Group Co.,Ltd.Chengdu Kanghong Pharmaceutical Group Co.,Ltd.国药准字H202444262024/07/09Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.

NameCompany / applicantRegistration numberStatusSource update dateView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/17
Chemical-drug catalogue
Last successful update: 2026/11/17
API registrations
Last successful update: 2026/11/17
NMPA drug delivery notices
Last successful update: 2026/11/17

Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.